Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Ayala Pharmaceuticals
Tel Aviv, IsraelFounded 2017Mar 2019
Ayala Pharmaceuticals
Amount raised
€26M
€25,800,000
Native amount
30,000,000 USD
Stage
Series B
series b
Investors
1

Provenance & confidence

High confidence
Amount
30,000,000 USD
ECB-at-date → €27M · rate 1.1235 on 2019-03-29
stored → €26M
High confidence
Source

nocamels.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

1
Date
Mar 2019
Round type
series b
Amount (EUR)
€26M

Other rounds

same company

This is the company's only recorded round.

Related news